Latest Regulatory News

Venus Metals Corporation has updated its Mineral Resource Estimate for the Bellchambers Gold Deposit and Rangeview Prospect near Sandstone, revealing a notable increase in measured resources and securing a mining lease that advances the project towards development.

Sarama Resources Ltd reported a $1.22 million net loss for the first half of 2025, while completing a $2.7 million equity placement and acquiring a majority stake in the Mt Venn Gold Project in Western Australia.

Adriatic Metals shareholders have overwhelmingly approved Dundee Precious Metals’ recommended acquisition scheme, clearing a major hurdle toward completion. Key regulatory approvals are in place, with the final court sanction hearing scheduled for late August.

Laramide Resources has made significant progress in advancing its uranium projects across the US, Australia, and Kazakhstan, highlighted by key permitting milestones under the US FAST-41 framework and a successful $12 million private placement to fund development.

Laramide Resources Ltd. reported a reduced net loss of CAD 1.05 million for H1 2025, converting USD 3.5 million of debt into equity and securing a $12 million private placement to bolster its uranium exploration projects.

Cochlear Limited has announced a fully franked ordinary dividend of AUD 2.15 per share for the six months ending June 2025, payable in October with multi-currency options for shareholders.

HealthCo Healthcare and Wellness REIT reported a substantial $89.3 million loss for FY25, driven by tenant payment issues and portfolio downsizing, leading to suspended distributions and a debt facility extension.

Xstate Resources has secured over $2 million from more than 300 new investors in its Re-compliance Prospectus offer, positioning itself for a potential return to ASX trading by early September.

Ampol Limited has announced a proposed $1.1 billion acquisition of EG Group Australia, significantly expanding its retail network and accelerating its U-GO brand rollout. The deal promises strong earnings accretion and cost synergies, pending regulatory approval.

Ampol has agreed to acquire EG Australia for $1.1 billion, significantly expanding its retail footprint and accelerating its convenience retail strategy. The deal promises strong financial returns and awaits regulatory approval.

Renergen Limited has received a crucial Competition Commission approval, enabling it to move forward with integration plans alongside ASP Isotopes Inc despite a slight delay in the Scheme timetable.

BPH Energy has responded to an ASX price query following unusual trading activity, confirming no undisclosed information exists and pointing to ongoing legal matters involving its investee Advent Energy as context.